It has been proposed that fixed-dose combination (FDC) polypills could reduce major acute cardiovascular events (MACE) and improve medications adherence in secondary prevention of cardiovascular disease (CVD). This editorial will address this and look at the existing evidence in the literature with a focused review on the SECURE trial.
Author Sub-editor: Dr May Hu Dr May Hu is a cardiology trainee in the North West deanery. She graduated with First Class Honours from the University
Author Sub-editor: Dr Jhiamluka Solano Dr Jhiamluka Solano is a cardiology resident doctor (ST6) in the Yorkshire and Humber Deanery, currently undertaking a DPhil (PhD)
Author Sub-editor: Dr Justin Chiong Dr Justin Chiong is an NIHR Academic Clinical Fellow and Cardiology Registrar in the North West Deanery. He graduated from
Author Heartbeat Sub-Editor: Marina Zafeiri Dr Marina Zafeiri is an IMT3 in the Wessex deanery, with a strong interest in Cardiology. She graduated from Athens
Author Heartbeat Sub-Editor: Toby MacCarthy Author: Toby MacCarthy
Author Heartbeat Sub-Editor: Toby MacCarthy Author: Toby MacCarthy
